351 related articles for article (PubMed ID: 14532772)
1. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
Konety BR; Joslyn SA
J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
[TBL] [Abstract][Full Text] [Related]
2. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
Konety BR; Joslyn SA; O'Donnell MA
J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
[TBL] [Abstract][Full Text] [Related]
3. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
4. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
6. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program.
Konety BR; Dhawan V; Allareddy V; Joslyn SA
J Urol; 2005 Jun; 173(6):2085-9. PubMed ID: 15879848
[TBL] [Abstract][Full Text] [Related]
7. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
8. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
9. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
11. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
[TBL] [Abstract][Full Text] [Related]
12. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
Nemani D; Mitra N; Guo M; Lin L
Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
[TBL] [Abstract][Full Text] [Related]
13. Surgical factors influence bladder cancer outcomes: a cooperative group report.
Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
[TBL] [Abstract][Full Text] [Related]
14. The impact of primary stage on survival in patients with lymph node positive bladder cancer.
Vieweg J; Gschwend JE; Herr HW; Fair WR
J Urol; 1999 Jan; 161(1):72-6. PubMed ID: 10037372
[TBL] [Abstract][Full Text] [Related]
15. Superiority of ratio based lymph node staging for bladder cancer.
Herr HW
J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
[TBL] [Abstract][Full Text] [Related]
16. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older.
Hollenbeck BK; Miller DC; Taub D; Dunn RL; Underwood W; Montie JE; Wei JT
Urology; 2004 Aug; 64(2):292-7. PubMed ID: 15302481
[TBL] [Abstract][Full Text] [Related]
17. Hospital lymph node counts and survival after radical cystectomy.
Hollenbeck BK; Ye Z; Wong SL; Montie JE; Birkmeyer JD
Cancer; 2008 Feb; 112(4):806-12. PubMed ID: 18085612
[TBL] [Abstract][Full Text] [Related]
18. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
